Abstract:Objective To investigate the effect of tandem mass spectrometry and gas chromatography-mass spectrometry to make prenatal diagnosis of methylmalonic acidemia (MMA) by detecting organic acid and acylcarnitine in amniotic fluid.Methods From October 11,2007 to December 20,2014,131 pregnant women with MMA proband received prenatal diagnosis of MMA in Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (case group).Another 120 cases of pregnant women for conventional prenatal diagnosis at the same period were as control group.The pregnant women of two groups had the amniocentesis at 16 to 20 weeks of gestation.The levels of propionylcarnitine(C3) and acetylcarnitine(C2)in amniotic fluid were detected by tandem mass spectrometry.The methylmalonic acid and methylcitrate acid were detected by gas chromatography-mass spectrometry.MMA gene of cells in amniotic fluid of eighty fetuses with proband clearly diagnosed were detected by gene testing.Data were analyzed by Wilcoxon test.Results In case group,29 fetuses were found positive for higher level of C3,C3/C2,methylmalonic acid and methylcitrate acid compared with normal reference value,and the detected rate of fetal MMA was 22.1％(29/131).The levels of C3 and C3 / C2 in amniotic fluid of these 29 cases were higher than those in control group[8.13(2.42-16.70) vs 1.04(0.52-3.40) μmol/L,Z =-8.313; 0.77(0.30-1.79) vs 0.10(0.05-0.22),Z=-8.374; P ＜ 0.05 respectively].The levels of methylmalonic acid and methylcitrate acid were also higher[9.13(1.68-61.78) vs 0.00(0.00-1.31) mmol/mol Crea,Z=-11.348; 0.58(0.00-1.90) vs 0.05(0.00-0.52) mmol/mol Crea,Z=-6.632,P ＜ 0.05 respectively].For the other 102 cases in case group,the levels of C3,C3/C2,methylmalonic acid and methylcitrate acid were not higher than normal reference value,and were similar to those in control group (P ＞ 0.05); while they were lower than those of positive MMA fetuses (all P ＜ 0.05).Among 29 positive fetuses,16 fetuses were detected MMA gene,five were diagnosed as MUT forms of MMA and 11 were MMACHC forms of MMA.In 102 MMA negative fetuses,64 fetuses were detected MMA gene,44 were found one mutant site and 20 were found no gene mutation.The coincidence rate between gene detecting and mass spectrometry was 100％(80/80).Conclusions Mass spectrometry could be used to measure the C3,methylmalonic acid and methylcitrate acid levels in amniotic fluid of pregnant women with MMA proband to make prenatal diagnosis.

Improving the second-tier classification of methylmalonic acidemia patients using a machine learning ensemble method

Improving methylmalonic acidemia (MMA) screening and MMA genotype prediction using random forest classifier in two Chinese populations

Efficient Mass Spectrometric Characterization and Classification of Methylmalonic Aciduria Subtypes Through Urinary and Blood Metabolic Profiles Fusion

Prenatal diagnosis of methylmalonic aciduria from amniotic fluid using genetic and biochemical approaches.

Phenotypic and genotypic analysis of children with methylmalonic academia: A single-center study in China and a recent literature review

A Rapid, Simple, Trace, Cost-Effective, and High-Throughput Stable Isotope-Dilution Liquid Chromatography–Tandem Mass Spectrometry Method for Serum Methylmalonic Acid Quantification and Its Clinical Applications

Clinical and genetic analysis of methylmalonic aciduria in 60 patients from Southern China: a single center retrospective study

Newborn Screening for Methylmalonic Aciduria by Tandem Mass Spectrometry: 7 Years' Experience from Two Centers in Taiwan.

Methylmalonic acidemia: Neurodevelopment and neuroimaging

The significance of machine learning in neonatal screening for inherited metabolic diseases

Involvement of Protein Phosphatases in Gonadotropin Releasing Hormone Regulated Gonadotropin Secretion

Comparing amniotic fluid mass spectrometry assays and amniocyte gene analyses for the prenatal diagnosis of methylmalonic aciduria

Integration of Machine Learning Techniques as Auxiliary Diagnosis of Inherited Metabolic Disorders - Promising Experience with Newborn Screening Data.

Multi-disciplinary interventions for the management and prevention of methylmalonic academia

[Clinical features and follow-up study on 55 patients with adolescence-onset methylmalonic acidemia]

Efficient and novel multidomain feature analysis model with incremental optimizations for enhancing pediatric myelodysplastic syndrome detection

Prenatal Diagnosis of Methylmalonic Acidemia by Amniotic Fluid Metabolites Analysis Using Mass Spectrometry

Insights into the Molecular Mechanisms of Methylmalonic Acidemia Using Microarray Technology.

[Research progress on the prognosis of patients with various types of Methylmalonic acidemia].

The follow-up of Chinese patients in mut-type methylmalonic acidemia identified through expanded newborn screening

Evaluation of the Clinical, Biochemical, Genotype and Prognosis Ofmut-Type Methylmalonic Acidemia in 365 Chinese Cases